CTT Pharmaceutical Holdings, Inc.: CEO bought 2,000 shares

What happened

• The Form 4 shows the company's CEO and director bought 2,000 shares in an open market or private purchase (transaction code P) on Oct 15, 2026 at $0.06 per share, for a total of $114. The Form 4 was filed on Oct 19, 2026.

Key details

• Transaction date and price: Oct 15, 2026 — purchase of 2,000 shares at $0.06 per share (total $114).
• Shares owned after the transaction: the filing does not report shares owned after the transaction in the provided details.
• Footnotes and plans: the transaction is reported with code P (purchase); no 10b5-1 plan, tax withholding, or other footnote details are shown in the provided transaction data.
• Filing date and accession: Form 4 filed Oct 19, 2026 (accession 0001035422-26-000017).

Why it may matter

• This was a purchase (transaction code P), not an option exercise, award, or gift.
• A filing does not show why the insider traded or why the company acted.